BioCentury | Apr 10, 2006
Company News

BioInvent, Immusol deal

...preclinical antibody to treat age-related macular degeneration (AMD). BINV will provide the human antibody, and Immusol...
...target. The companies will share costs and potential revenues. BioInvent International AB (SSE:BINV), Lund, Sweden Immusol Inc....
BioCentury | Feb 6, 2006
Company News

Immusol, Baylor College of Medicine deal

...Baylor granted Immusol an exclusive worldwide license to a preclinical oncolytic viral therapy to treat solid...
...a preclinical oncolytic viral therapy to treat solid tumors. The therapy uses herpes simplex viruses. Immusol Inc....
BioCentury | Jan 16, 2006
Company News

MultiCell Technologies management update

...Technologies Inc. (MCET), Lincoln, R.I. Business: Neurology Hired: Gerard Wills as CFO, formerly CFO at Immusol Inc. WIR...
BioCentury | Jun 6, 2005
Company News

Immusol management update

Immusol Inc. , San Diego, Calif. Business: Cardiovascular, Infectious Hired: Barry Simon as VP of clinical and regulatory affairs, formerly an industry consultant WIR Staff...
BioCentury | Jul 26, 2004
Company News

CytRx management update

...and Jack Barber as SVP of drug development, formerly CTO and VP of R&D at Immusol Inc. WIR...
BioCentury | Jun 28, 2004
Company News

Affymetrix, Immusol deal

...biological assays. Immusol retains all rights to any discoveries. Affymetrix Inc. (AFFX), Santa Clara, Calif. Immusol Inc....
BioCentury | Mar 15, 2004
Company News

Adventrx management update

...as VP of clinical and medical affairs, formerly director of product development and preclinical for Immusol Inc. WIR...
BioCentury | Jan 26, 2004
Company News

Immusol management update

Immusol Inc. , San Diego, Calif. Business: Cardiovascular, Infectious, Cancer Hired: Nicholas Paoni as VP of therapeutics, formerly research professor in the department of chemistry and biochemistry at the University of Notre Dame; and Clark Springgate...
BioCentury | Sep 29, 2003
Company News

Immusol, Novartis deal

...NVS made a $10 million equity investment in Immusol under a 2001 deal to discover cancer...
...was triggered by Immusol delivering to NVS a specified number of genes involved in oncogenesis. Immusol Inc....
BioCentury | Apr 21, 2003
Clinical News

VIT100: Phase I

...Immusol reported the start of a physician-sponsored U.S. Phase I study in 20 patients. Immusol Inc....
Items per page:
1 - 10 of 42
BioCentury | Apr 10, 2006
Company News

BioInvent, Immusol deal

...preclinical antibody to treat age-related macular degeneration (AMD). BINV will provide the human antibody, and Immusol...
...target. The companies will share costs and potential revenues. BioInvent International AB (SSE:BINV), Lund, Sweden Immusol Inc....
BioCentury | Feb 6, 2006
Company News

Immusol, Baylor College of Medicine deal

...Baylor granted Immusol an exclusive worldwide license to a preclinical oncolytic viral therapy to treat solid...
...a preclinical oncolytic viral therapy to treat solid tumors. The therapy uses herpes simplex viruses. Immusol Inc....
BioCentury | Jan 16, 2006
Company News

MultiCell Technologies management update

...Technologies Inc. (MCET), Lincoln, R.I. Business: Neurology Hired: Gerard Wills as CFO, formerly CFO at Immusol Inc. WIR...
BioCentury | Jun 6, 2005
Company News

Immusol management update

Immusol Inc. , San Diego, Calif. Business: Cardiovascular, Infectious Hired: Barry Simon as VP of clinical and regulatory affairs, formerly an industry consultant WIR Staff...
BioCentury | Jul 26, 2004
Company News

CytRx management update

...and Jack Barber as SVP of drug development, formerly CTO and VP of R&D at Immusol Inc. WIR...
BioCentury | Jun 28, 2004
Company News

Affymetrix, Immusol deal

...biological assays. Immusol retains all rights to any discoveries. Affymetrix Inc. (AFFX), Santa Clara, Calif. Immusol Inc....
BioCentury | Mar 15, 2004
Company News

Adventrx management update

...as VP of clinical and medical affairs, formerly director of product development and preclinical for Immusol Inc. WIR...
BioCentury | Jan 26, 2004
Company News

Immusol management update

Immusol Inc. , San Diego, Calif. Business: Cardiovascular, Infectious, Cancer Hired: Nicholas Paoni as VP of therapeutics, formerly research professor in the department of chemistry and biochemistry at the University of Notre Dame; and Clark Springgate...
BioCentury | Sep 29, 2003
Company News

Immusol, Novartis deal

...NVS made a $10 million equity investment in Immusol under a 2001 deal to discover cancer...
...was triggered by Immusol delivering to NVS a specified number of genes involved in oncogenesis. Immusol Inc....
BioCentury | Apr 21, 2003
Clinical News

VIT100: Phase I

...Immusol reported the start of a physician-sponsored U.S. Phase I study in 20 patients. Immusol Inc....
Items per page:
1 - 10 of 42